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612Objectives: Thoracic endovascular aortic repair (TEVAR) has been gaining popularity for the treatment of thor-
acoabdominal aortic aneurysm (TAAA). We used a nonvoluntary database to examine national trends and re-
gional/hospital variations in the use of TEVAR and open thoracic aortic repair (OTAR) for TAAA.
Methods: From the 2005-2008 Nationwide Inpatient Sample database, we identified all patients with the diag-
nosis of TAAA who were treated with TEVAR or OTAR. Rates of these procedures were compared between
years, across geographic regions, and between hospitals of various bed sizes.
Results: Over the study period, the rate of OTAR remained relatively stable (range, 7.5/100 patients in 2005 to
10.1/100 patients in 2008; P¼ .26), whereas the rate of TEVAR increased dramatically (range, 1.4/100 patients
in 2005 to 6.3/100 patients in 2008; P<.0001). In 2008, 29% (211) of all TEVAR procedures and 11% (130) of
all OTAR procedures were performed in western regions of the United States (P¼ .03). Additionally, 13% (95)
of all TEVAR procedures and 3% (35) of all OTAR procedures were performed in smaller hospitals (P<.0001).
Conclusions: The use of TEVAR for TAAA repair increased significantly over the study period, whereas OTAR
rates remained relatively stable. Our findings suggest that more patients who were otherwise not surgical can-
didates or did not have traditional surgical indications for OTAR were treated with TEVAR, most commonly in
regions or hospitals where OTAR is less often performed. Given the complexity of TAAA cases, these results
may have significant implications for patient safety in the current era of heightened health care scrutiny.
(J Thorac Cardiovasc Surg 2012;144:612-6)After endovascular techniques were developed for the man-
agement of abdominal aortic aneurysms in 1991, they com-
peted with open aortic repair and have become the primary
treatment modality for many patients with isolated aortic
aneurysms.1-3 Endovascular interventions for aneurysm
repair were further refined after the technology for
thoracic endovascular aortic repair (TEVAR) was
approved by the US Food and Drug Administration in
2005 for use in the repair of thoracic aortic aneurysms,4
leading to an increased use of stent grafts in repairing
some thoracic aortic aneurysms. Since then, TEVAR has
been rapidly gaining popularity.
Preliminary short-term data regarding the use of TEVAR to
treat thoracic aortic aneurysms have been promising.5 Inter-
mediate outcomes for TEVAR in the treatment of thoracic aor-
tic aneurysms, first described in several single-center studies,6
were further elucidated in a nationwide study that aimed toaylor College of Medicinea and the Texas Heart Institute at St Luke’s Epis-
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with better in-hospital outcomes, shorter lengths of stay, and
fewer complications thanopen thoracic aortic repair (OTAR).7
Thoracoabdominal aortic aneurysm (TAAA) is a rare but
complex and potentially lethal disease with relatively high
perioperative morbidity and mortality. Historically, TAAA
has required open surgical repair.8,9 The overall rupture rate
is estimated to be as high as 26%,10 and rupture is associated
with anoverallmortality rate of 20.3%.11 Postrepair and peri-
operative mortality rates from experienced centers range
from approximately 4% to 16%.12-16 Given the relatively
high morbidity and mortality of open surgical TAAA
repair, less-invasive TEVAR procedures with adjunctive sur-
gical visceral vessel debranching (hybrid approach) and TE-
VARalonewith specialized branched endografts have slowly
emerged as feasible and promising alternatives.17-20
However, little is known about regional and hospital var-
iation in the use of TEVAR for the treatment of TAAA. We
examined nationwide trends and attempted to determine
whether there is any regional or hospital variation in the
use of TEVAR versus OTAR for the treatment of TAAA.MATERIALS AND METHODS
Data Source
Data were collected from the 2005-2008 Nationwide Inpatient Sample
(NIS). The NIS is a database of hospital inpatient stays and is maintained
by the Agency for Healthcare Research and Quality as part of the Healthcare
Cost and Utilization Project (HCUP).21 The NIS is the largest all-payerery c September 2012
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nonfederal facilitieswithin theUnited States. TheNIShas numerous internal
quality assurance procedures that check the consistency and validity of data
points (http://www.hcup-us.ahrq.gov/db/quality.jsp). Furthermore, HCUP
validates the NIS annually by comparing its contents with those of 2 similar
databases, the National Hospital Discharge Survey and the Medicare Pro-
vider Analysis and Review, to assess potential biases in the dataset (http://
www.hcup-us.ahrq.gov/db/nation/nis/nisrelatedreports.jsp). The NIS con-
tains data on approximately 8 million hospital stays each year from more
than 1000 hospitals. Weights based on sampling probabilities for each stra-
tum are used in the analysis to ensure that the hospitals studied are represen-
tative of all US hospitals. Five hospital sampling strata were defined
according to hospital characteristics contained in theAmericanHospital As-
sociation Annual Survey of Hospitals. The stratification variables were geo-
graphic region (Appendix Table 1), location (urban or rural), teaching status,
control (public or proprietary), and bed size (Appendix Table 2).
This studywas approved by the Institutional ReviewBoard ofBaylorCol-
legeofMedicine.The reporteddata conform to the data-useagreement for the
NIS from the HCUP. Additional information about NIS is available from the
Agency forHealthcare Research andQuality, which administers the database
as part of the HCUP (http://www.hcup-us.ahrq.gov/nisoverview.jsp).
Patient Selection
Patient identificationwasbasedon the2008 InternationalClassification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and
procedure codes.22 We used the these codes to query the 2005-2008 NIS da-
tabase for our patient selection. The ICD-9 diagnosis codes 4416 and 4417
were used to identify all patients with TAAA. Within this group of patients,
the ICD-9 procedure codes 3835 and 3845were used to identify patients who
underwentOTARonlywithout any endovascular intervention, and procedure
code 3973was used to identify patientswho underwent TEVARwith orwith-
out a hybrid debranching procedure. We excluded patients who underwent
both TEVAR and OTAR during the same index hospitalization in an attempt
to exclude emergency open conversions from our final analysis.
We found a total of 39,135 records of patients with the diagnosis of TAAA
whowere discharged from a hospital during the 4-year study period. Of these
patients, 2911underwentOTARonly, and1838underwentTEVARalonewith
branchedendografts or TEVARwith a hybrid visceral debranching procedure.
Statistical Analysis
NIS database dischargeweights were used to produce national estimates
for all analyses. Rates of TEVAR and OTAR were then compared by year,
geographic region (Appendix Table 1), and hospital bed size (Appendix
Table 2) by using the Rao-Scott c2 test. All data were analyzed with
SAS/STAT software, version 9.1, of the SAS System for the XP PRO plat-
form (SAS Institute Inc, Cary, NC).
RESULTS
As shown in Figure 1, the rate ofOTAR remained relatively
stable over the studyperiod (7.5/100TAAApatients in 2005vsThe Journal of Thoracic and Ca10.1/100TAAApatients in 2008;P¼ .26). In contrast, the rate
of TEVAR increased significantly, from 1.4/100 TAAA pa-
tients in 2005 to 6.3/100 TAAA patients in 2008 (P<.0001).
In the most recent data set (from 2008), 29% of all
TEVAR procedures were performed in western regions of
the United States (as defined in Appendix Table 1), whereas
only 11% of all OTAR procedures were performed in those
regions (Table 1). Similarly, in 2008, 13% of all TEVARpro-
cedures were performed in small bed size hospitals (as de-
fined in Appendix Table 2), whereas only 3% of all OTAR
procedures were performed in small hospitals (Table 2).
DISCUSSION
We found that whereas OTAR rates remained relatively
stable over the 4-year study period, TEVAR rates signifi-
cantly increased over the same period for the treatment of
TAAA. Moreover, the rates of TEVAR and OTAR varied
among regions and by hospital bed size, in that more TE-
VAR procedures than OTAR procedures were performed
in western regions of the United States and in smaller hos-
pitals across the country.
Because of both theminimal invasiveness of TEVARcom-
pared with OTAR and patient-driven demand for TEVAR
technology, TEVAR rates for the treatment of TAAA rapidly
increased between 2005 and 2008, whereas rates of OTAR
for TAAA remained relatively unchanged during the same
period. Although these results are not unexpected, the re-
gional and hospital variation in the use of these procedures
is a novel finding and may have significant implications.
Open surgical TAAA repairs are complex surgical proce-
dures, the outcomes of which have been shown to be best at
high-volume centers with high-volume surgeons.23 For this
reason, OTAR for TAAA repair often requires a dedicated
team of surgeons, anesthesiologists, ancillary support staff,
and hospital resources to achieve optimal outcome.Although
TEVAR is less invasive than OTAR, intraoperative conver-
sion to emergencyOTAR—the probability ofwhich is not in-
significant—carries a high mortality and morbidity rate.24
Our study shows significant regional and hospital varia-
tion in the rates of TEVAR and OTAR procedures for the
treatment of TAAA. Specifically, a higher percentage of
TEVAR procedures than OTAR procedures was performed
in western regions of the United States and in smaller hos-
pitals (Tables 1 and 2). When complications from TEVAR
procedures occur in regions or hospitals where OTAR is
less commonly performed, emergency open conversion
must be done in a setting where resources and experience
may be limited. This situation is probably not uncommon,
because conversion to OTAR is necessary in approximately
4% of TEVAR procedures performed to treat thoracic aor-
tic disease of any sort.24 The outcomes of these emergency
conversions may be compromised in such cases.
Regional variations in the rates of TEVAR identified in
our study may have been due to population density variancerdiovascular Surgery c Volume 144, Number 3 613
FIGURE 1. Nationwide trends in the rate of open versus endovascular repair of thoracoabdominal aortic aneurysm (TAAA). TEVAR, Thoracic endovascular
aortic repair; OTAR, open thoracic aortic repair.
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Specifically, western and northeastern regions account
for approximately 22% and 17% of the overall US popula-
tion, respectively (www.census.gov/prod/cen2010/briefs/
c2010br-01.pdf). Assuming equal prevalence of TAAA
across the country, each of these 2 regions are performing
7% more TEVAR than expected when compared with their
population densities (Table 1). Along the same line of rea-
soning, the western region is performing 11% fewer
OTAR procedures while the northeastern region is perform-
ing 20% more OTAR procedures (Table 1). Even after ad-
justing for population density differences, our study
continued to support the observation that TEVAR proce-
dures are being performed more commonly in regions
(such as the west) where OTAR is less often performed.
This observation along with hospital variation in TEVAR/
OTAR procedures ultimately may have significant patient
safety implications, as previously suggested.
Our study is subject to the limitations inherent in a retro-
spective review and in the use of an administrative database
like that of the NIS. As such, wewere not able to obtain spe-
cific operative procedure details (pure endograft vs hybrid)
or clinical outcome information, and there may have been
reporting bias owing to coding errors. However, the focus
of our study was on the health-service implications of trends
in TEVAR and OTAR use, not on clinical outcomes, and any
potential reporting bias would have been equally distributed
between the TEVAR and OTAR cases. Also, although the
NIS database provides a significant amount of information
on hospital characteristics, it does not adjust for the volumeTABLE 1. Regional variation in the treatment of thoracoabdominal
aortic aneurysms in 2008
Procedure
Region P
valueNortheast Midwest South West
OTAR 436 (37%) 353 (30%) 259 (22%) 130 (11%) .03
TEVAR 176 (24%) 124 (17%) 219 (30%) 212 (29%)
US geographic regions are those described on the Nationwide Inpatient Sample data-
base Web site (http://www.hcup-us.ahrq.gov/db/vars/h_region/nisnote.jsp). OTAR,
Open thoracic aortic repair; TEVAR, thoracic endovascular aortic repair.
614 The Journal of Thoracic and Cardiovascular Surgof cases performed by individual surgeons, nor does it in-
clude specific data regarding the anatomic extent of each
patient’s TAAA. Nonetheless, the large sample size of our
database allowed us to identify significant regional and
hospital variations. Also, the nonvoluntary nature of the
NIS database provides a novel ‘‘real-world’’ snapshot of
TEVAR/OTAR trends and variations in the treatment of
TAAA.
Future research efforts should focus on exploring the
mechanisms underlying these regional and hospital
variations. Previous research has suggested that regionaliz-
ing procedures associated with high perioperative mortality
rates such as open surgical TAAA repair and endovascular
repair for ruptured abdominal aortic aneurysms would
improve outcomes.23,25 However, it is unclear whether
this would also be true for TAAA repairs with TEVAR.
As TEVAR technology improves with the advent of
customizable visceral branched endografts, the
endovascular skills necessary for TAAA TEVAR may
become increasingly difficult to master. Regionalization
of TAAA patients to high-volume specialized aortic centers
of excellence may be needed to achieve excellent outcomes
and provide optimal patient safety.
In conclusion, our results suggest that there are signifi-
cant national trends and variations in the use of TEVAR ver-
sus OTAR for TAAA repair, and these differences may have
important health care and patient safety implications. Fur-
ther work is needed to identify the mechanisms that underlie
these observed variations and to determine what implica-
tions these disparities have for patient outcomes.TABLE 2. Hospital variation in the treatment of thoracoabdominal
aortic aneurysms in 2008
Procedure
Hospital bed size P
valueSmall Medium Large
OTAR 35 (3%) 47 (4%) 1096 (93%) <.0001
TEVAR 95 (13%) 80 (11%) 556 (76%)
Hospital bed size categories are those described on the Nationwide Inpatient Sample
database Web site (http://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp).
OTAR, Open thoracic aortic repair; TEVAR, thoracic endovascular aortic repair.
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APPENDIX TABLE 2. Hospital bed size
Location and teaching status
Hospital bed size
Small Medium Large
Northeast region
Rural 1-49 50-99 100þ
Urban, nonteaching 1-124 125-199 200þ
Urban, teaching 1-249 250-424 425þ
Midwest region
Rural 1-29 30-49 50þ
Urban, nonteaching 1-74 75-174 175þ
Urban, teaching 1-249 250-374 375þ
Southern region
Rural 1-39 40-74 75þ
Urban, nonteaching 1-99 100-199 200þ
Urban, teaching 1-249 250-449 450þ
Western region
Rural 1-24 25-44 45þ
Urban, nonteaching 1-99 100-174 175þ
Urban, teaching 1-199 200-324 325þ
Hospital bed size categories are those described on the Nationwide Inpatient Sample
database Web site (http://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp).
APPENDIX TABLE 1. Geographic regions
Geographic
region States
Northeast ME, NH, VT, MA, RI, CT, NY, NJ, PA
Midwest OH, IN, IL, MI, WI, MN, IA, MO, ND, SD, NE, KS
South DE, MD, DC, VA, WV, NC, SC, GA, FL, KY, TN, AL, MS,
AR, LA, OK, TX
West MT, ID, WY, CO, NM, AZ, UT, NV, WA, OR, CA, AK, HI
US geographic regions are those described on the Nationwide Inpatient Sample data-
base Web site (http://www.hcup-us.ahrq.gov/db/vars/h_region/nisnote.jsp).
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